For years, patients and surgeons reported that the Cartiva implant was failing at alarming rates. Yet, the device remained on the market. That changed in October 2024, when a Class II Device Recall was finally initiated for the Cartiva Synthetic Cartilage Implant.
What the Recall Says: The recall notice acknowledges what victims have known for years: the device has a "higher-than-expected occurrence rate" of failure.
Why This Matters for Your Case: A recall is a critical piece of evidence. It suggests that the manufacturer acknowledges the product is not performing as represented. If you received a Cartiva implant, your device is part of this recall. Contact us today to discuss your options.
Joshua S. Kincannon
Shareholder
Lynne M. Kizis
Co-Chair, Mass Tort/Class Action Team
Shareholder